Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: A meta-analysis

Journal of the National Cancer Institute

Volumn 101, Issue 15, 2009, Pages 1066-1082

  Liu, Shijian ^a   Zhang, Hongwei ^a   Gu, Chunying ^a   Yin, Jianhua ^a   He, Yongchao ^a   Xie, Jiaxin ^a   Cao, Guangwen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; PRES (120 145) PEPTIDE; PRES (120-145) PEPTIDE; PROTEIN PRECURSOR; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; CHRONIC HEPATITIS; COHORT ANALYSIS; DATA BASE; DISEASE ASSOCIATION; DISEASE COURSE; ENHANCER REGION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; UNINDEXED SEQUENCE; VIRUS MUTATION; BLOOD; EPIDEMIOLOGY; GENETICS; HEPATITIS C; IMMUNOLOGY; LIVER TUMOR; META ANALYSIS; METHODOLOGY; MUTATION; PREDICTION AND FORECASTING; RISK; SENSITIVITY AND SPECIFICITY; VIROLOGY;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DNA, VIRAL; GENOTYPE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MUTATION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; VIRAL ENVELOPE PROTEINS;

EID: 68249152595     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp180     Document Type: Article

References (68)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557-2576.
2. Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol. 2000;14(8):703-709.
3. Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res. 2007;127(2):164-176.
4. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006;43(2)(suppl 1):S173-S181.
5. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295(1):65-73.
6. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002;347(3):168-174.
7. Schaefer S. Hepatitis B virus: significance of genotypes. J Viral Hepat. 2005;12(2):111-124.
8. Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma:a prospective study in men. J Natl Cancer Inst. 2005;97(4):265-272.
9. Ni YH, Chang MH, Wang KJ, et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology. 2004;127(6):1733-1738.
10. Yin J, Zhang H, Li C, et al. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Carcinogenesis. 2008;29(9):1685-1691.
11. Chan HL, Tse CH, Mo F, et al. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. J Clin Oncol. 2008;26(2):177-182.
12. Tanaka Y, Mukaide M, Orito E, et al. Specific mutations in enhancer 11/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol. 2006;45(5):646-653.
13. Yuan J, Zhou B, Tanaka Y, et al. Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications. J Clin Virol. 2007;39(2):87-93.
14. Sung JJ, Tsui SK, Tse CH, et al. Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus. J Virol. 2008;82(7):3604-3611.
15. Kao JH, Chen PJ, Lai MY, Chen DS. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology. 2003;124(2):327-334.
16. Lin CL, Liu CH, Chen W, et al. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol. 2007;22(7):1098-1103.
17. Liu CJ, Chen BF, Chen PJ, et al. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. J Infect Dis. 2006;193(9):1258-1265.
18. Mu SC, Lin YM, Jow GM, Chen BF. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol. 2009;50(2):264-272.
19. Chen CH, Hung CH, Lee CM, et al. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology. 2007;133(5):1466-1474.
20. Ozasa A, Tanaka Y, Orito E, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology. 2006;44(2):326-334.
21. Nishizono A, Kohno K, Takita-Sonoda Y, et al. Sequential analyses of the mutations in the core upstream and precore regions of hepatitis B virus genome in anti-HBe positive-carriers developing acute exacerbation. J Med Virol. 1997;53(3):266-272.
22. Livingston SE, Simonetti JP, McMahon BJ, et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis. 2007;195(1):5-11.
23. Truong BX, Yano Y, Seo Y, et al. Variations in the core promoter/precore region in HBV genotype C in Japanese and Northern Vietnamese patients. J Med Virol. 2007;79(9):1293-1304.
24. Chan HL, Hui AY, Wong ML, et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut. 2004;53(10):1494-1498.
25. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208-1236.
26. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45(2):507-539.
27. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
28. Sterne J A, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046-1055.
29. Cao Z, Bai X, Guo X, et al. High prevalence of hepatitis B virus pre-S mutation and its association with hepatocellular carcinoma in Qidong, China. Arch Virol. 2008;153(10):1807-1812.
30. Deng SL, Cheng W, Yuan T. Study on HBV DNA concentration and HBV C gene promoter mutation of hepatoma patients [in Chinese]. J Chongqing Med. 2004;33(6):880-881.
31. Ding HF, Tian D, Yang D, Pi B, Xu D. Clinical study on the relationships between HBV genotype and HBV basic core promoter mutants in HCC patients [in Chinese]. Chin J Integ Trad West Med Liver Dis. 2006;16(4):206-209.
32. Fang ZL, Yang J, Ge X, et al. Core promoter mutations (A (1762) T and G (1764) A) and viral genotype in chronic hepatitis B and hepatocellular carcinoma in Guangxi, China. J Med Virol. 2002;68(1):33-40.
33. Gao ZY, Li T, Wang J, et al. Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma. J Gastroenterol. 2007;42(9):761-768.
34. Guo X, Jin Y, Qian G, Tu H. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatol. 2008;49(5):718-725.
35. Wang Z, Tanaka Y, Huang Y, et al. Clinical and virological characteristics of hepatitis B virus subgenotypes Ba, C1, and C2 in China. J Clin Microbiol. 2007;45(5):1491-1496.
36. Zhang F, Shao YF, Gao JD, et al. Risk features of HBV in human hepato-carcinogenesis:a nested case-controlled study [in Chinese]. Chin J Surg. 2007;45(21):1482-1484.
37. Zhang SH, Xi W, Yang Q, He A, Wang H. Double-position mutation in the basic core promoter of hepatitis B virus in relation to hepatoeirrhosis and liver cancer [in Chinese]. Mod Med Health. 2006;22(13):1924-1925.
38. Zhang YY, Wang AP, Tang Q. Relation of hepatits B virus gene mutation, genotype and hepatocellular carcinoma [in Chinese]. J Pract Med. 2007;23(21):3323-3325.
39. Zhou GP, Bai JY, Luo LB, et al. Effect of hepatitis B virus mutation and inactivation of p16 tumor suppressor on hepatocellular carcinoma [in Chinese]. J Shandong Med. 2007;47(35):26-28.
40. Zhu R, Zhang HP, Yu H, et al. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients. Pathol Res Pract. 2008;204(10):731-742.
41. Muroyama R, Kato N, Yoshida H, et al. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. J Hepatol. 2006;45(6):805-812.
42. Shinkai N, Tanaka Y, Ito K, et al. Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2. J Clin Microbiol. 2007;45(10):3191-3197.
43. Sugauchi F, Ohno T, Orito E, et al. Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J Med Virol. 2003;70(4):537-544.
44. Takahashi K, Ohta Y, Kanai K, et al. Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease. Arch Virol. 1999;144(7):1299-1308.
45. Chen BF, Liu CJ, Jow GM, et al. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology. 2006;130(4):1153-1168.
46. Chou YC, Yu MW, Wu CF, et al. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut. 2008;57(1):91-97.
47. Ni YH, Chang MH, Hsu HY, Tsuei DJ. Different hepatitis B virus core gene mutations in children with chronic infection and hepatocellular carcinoma. Gut. 2003;52(1):122-125.
48. Yang HI, Yeh SH, Chen PJ, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. 2008;100(16):1134-1143.
49. Tong MJ, Blatt LM, Kao JH, Cheng JT, Corey WG. Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma. World J Gastroenterol. 2006;12(41):6620-6626.
50. Tong MJ, Blatt LM, Kao JH, Cheng JT, Corey WG. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma:a comparison with chronic carriers. Liver Int. 2007;27(10):1356-1363.
51. Choi MS, Kim DY, Lee DH, et al. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat. 2007;14(3):161-168.
52. Jang JW, Lee YC, Kim MS, et al. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis. J Viral Hepat. 2007;14(3):169-175.
53. Kim HJ, Park JH, Jee Y, et al. Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection. J Med Virol. 2008;80(8):1337-1343.
54. Mun HS, Lee SA, Jee Y, et al. The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C. J Med Virol. 2008;80(7):1189-1194.
55. Yuen MF, Tanaka Y, Shinkai N, et al. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut. 2008;57(1):98-102.
56. Laskus T, Radkowski M, Nowicki M, et al. Association between hepatitis B virus core promoter rearrangements and hepatocellular carcinoma. Biochem Biophys Res Commun. 1998;244(3):812-814.
57. Mendy ME, Kaye S, Le Roux E, et al. The application of a novel, rapid and sensitive oligonucleotide ligation assay for the detection of cancer predicting mutations in the pre-core and basal core promoter of Hepatitis B virus. J Clin Microbiol. 2008;46(8):2723-2730.
58. Song LH, Duy DN, Binh VQ, et al. Low frequency of mutations in the X gene, core promoter and precore region of hepatitis B virus infected Vietnamese. J Viral Hepat. 2005;12(2):160-167.
59. Baptista M, Kramvis A, Kew MC. High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology. 1999;29(3):946-953.
60. Ito K, Tanaka Y, Orito E, et al. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. Clin Infect Dis. 2006;42(1):1-7.
61. Sakamoto T, Tanaka Y, Orito E, et al. Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines. J Gen Virol. 2006;87(pt 7):1873-1882.
62. Blackberg J, Kidd-Ljunggren K. Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma., J. Med Virol. 2003;71(1):18-23.
63. Huy TT, Ushijima H, Win KM, et al. High prevalence of hepatitis B virus pre-S mutant in countries where it is endemic and its relationship with genotype and chronicity. J Clin Microbiol. 2003;41(12):5449-5455.
64. Jammeh S, Tavner F, Watson R, Thomas HC, Karayiannis P. Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol. 2008;89(pt 4):901-909.
65. Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J. Virol. 1996;70(9):5845-5851.
66. Parekh S, Zoulim F, Ahn SH, et al. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J. Virol. 2003;77(12):6601-6612.
67. Fang ZL, Sabin CA, Dong BQ, et al. HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma:a prospective study. Am J Gastroenterol. 2008;103(9):2254-2262.
68. Lok AS. Prevention of hepatitis B virus-related hepatocellular carcinoma. Gastroenterology. 2004;127(5)(suppl 1):S303-S309.